Burundi vs Democratic People's Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burundi
0.4%
in 2024
Democratic People's Republic of Korea
0.4%
in 2024
Burundi rank
74th
Democratic People's Republic of Korea rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burundi
- Democratic People's Republic of Korea
How they compare
Burundi currently reports 0.4% against 0.4% in Democratic People's Republic of Korea, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Democratic People's Republic of Korea ahead.
Burundi ranks 74th and Democratic People's Republic of Korea ranks 74th of 246 countries.
Across the 2 decades both report, Burundi averaged higher in 1 and Democratic People's Republic of Korea in 1.
Head to head by decade
| Decade | Burundi | Democratic People's Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | Democratic People's Republic of Korea |
| 2020s | 0.4% | 0.3% | 0.1% | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burundi or Democratic People's Republic of Korea?
- Burundi, at 0.4% against 0.4% in Democratic People's Republic of Korea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burundi and Democratic People's Republic of Korea?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Democratic People's Republic of Korea?
- 10 years are reported by both, from 2015 to 2024.
- How do Burundi and Democratic People's Republic of Korea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burundi ranks 74th and Democratic People's Republic of Korea ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.